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Inmammals the twoproteins UCP2 andUCP3 are highly similar to the
mitochondrial uncoupling protein found in the brown adipose tissue
(UCP1). Accordingly, it was proposed that UCP2 and UCP3 are also
uncoupling proteins i.e. allowing proton reentry into mitochondrial
matrix in a regulatedwayandmoreover the regulation ofUCP1, UCP2 and
UCP3 were considered as similar by several authors. Our recent
publications [1–7] support the hypothesis is that the uncoupling activity
is not the reason toUCP2presence inmammals and conservation through
evolution of UCPs. 1) UCP2 expression is tightly controlled in the short
time. The UCP2 protein is very poorly expressed in comparison with the
mRNA content of a cell [1]. This is explained by (i) the constitutive
inhibition ofUCP2mRNA translation by the 5′untranslated region [2], (ii)
the short (20–30 min) half life of UCP2 [3]. Glutamine was shown to
relieve the constitutive inhibition of UCP2 translation [4]. This control of
expression by a known respiratory substrate points to the possibility that
UCP2 be more on the side of metabolism (substrate use) than
bioenergetics (respiratory control). 2) UCP2/3 influences cellular
metabolism in absence of uncoupling. Ucp2-KO mice show an alteration
of macrophage activity [8]. Studies comparing macrophages from Ucp2-
KO mice with their control showed disturbance of glutamine catabolism
[5]. Although respiration was faster in presence of UCP2 this increase
could not be explained by uncoupling but rather by a more efficient
substrate supply to mitochondria in presence of UCP2. Similarly it was
noticedmodification in cells recombinantly expressing UCP3 that did not
support uncoupling [6], this seems to be related to pyruvate metabolism
[6,7]. It is possible to feedmitochondrial oxidation by glutamine and fatty
acids in absence of glucose. The control of UCP2 expression is consistent
with the proposal that UCP2 would divert mitochondria from oxidizing
pyruvate when glutamine and fatty acids are available.
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Uncoupling proteins (UCP1, UCP2 and UCP3) are important in
regulating cellular fuel metabolism and as attenuators of reactive
oxygen species production, through strong or mild uncoupling. The
generic function and broad tissue distribution of the uncoupling
protein familymeans that they are increasingly implicated in a range of
pathophysiological processes including obesity, insulin resistance and
diabetes mellitus, neurodegeneration, cardiovascular disease, immu-
nity and cancer. The significant recent progress describing the turnover
of novel uncoupling proteins, as well as current views on the
physiological roles and regulation of UCPs, is outlined.
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The uncoupling proteins (UCPs) are mitochondrial transporters
whose biological function is, in principle, to modulate the efficiency
of the oxidative phosphorylation although the actual molecular
mechanism may vary among the different family members. Up till
now, only the physiological role of the uncoupling protein from
brown fat (UCP1) has been unequivocally defined: it is a regulated
proton carrier that allows the generation of heat for adaptive
thermogenesis. The function of the remaining members of the UCP
protein family is not established, but available data point to a role in
the antioxidant defence system [1,2]. Although the acceleration of
respiration due to UCP-mediated uncoupling would lead to a
reduction in the production of superoxide, it has also been proposed
that UCPs induce a metabolic shift that promotes glycolysis and
therefore indirectly lowers the mitochondrial production of reactive
oxygen species (ROS) [3]. Nevertheless, there are many examples
where UCPs are upregulated in physiological situations where there is
oxidative stress and data suggesting that their presence lowers ROS
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levels. The uncoupling protein UCP2 is found in many animal tissues
and organs and its expression levels are often increased in
pathological processes in which there is oxidative stress (lipotoxicity,
atherosclerosis, chronic inflammation, etc.). Tumour cells have a high
intrinsic level of oxidative stress and, in these cells, UCP2 can also
play a protective role that has made this protein a target for cancer
treatment [4]. Thus, it has been shown that in colon cancer UCP2
expression is increased and that this induction appears linked to NF-
κB activation and oxidative stress. Increased UCP2 levels have also
been associated with resistance to chemo- and radiotherapy in
sublines of leukemia and melanoma. Additionally, it has been shown
that overexpression of UCP2 in tumour cells reduces ROS levels and
apoptosis when treated with antitumour drugs such as doxorubicin
or camptothecin. We present data showing that inhibition of UCP2 in
tumour cells causes oxidative stress and that the inhibition acts
synergistically with chemotherapeutic agents to reduce cell viability.
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Uncoupling proteins (UCPs) are members of the mitochondrial
anion carrier protein family that are present in the mitochondrial
inner membrane and mediate free fatty acid (FFA)-activated, purine
nucleotide (PN)-inhibited proton conductance. Since 1999, the
presence of UCPs has been demonstrated in some non-photosynthe-
sising unicellular eukaryotes, including amoeboid and parasite
protists, as well as in non-fermentative yeast and filamentous fungi.
In the mitochondria of these organisms, UCP activity is revealed upon
FFA-induced, PN-inhibited stimulation of resting respiration and a
decrease in membrane potential, which are accompanied by a
decrease in membranous ubiquinone (Q) reduction level. UCPs in
unicellular eukaryotes are able to divert energy from oxidative
phosphorylation and thus compete for a proton electrochemical
gradient with ATP synthase. Our recent work indicates that
membranous Q is a metabolic sensor that might utilise its redox
state to release the PN-inhibition of UCP-mediated mitochondrial
uncoupling under conditions of phosphorylation and resting respira-
tion. As this regulatory feature was demonstrated for microorganism
UCPs (A. castellanii UCP), plant and mammalian UCP1 analogues, and
UCP1 in brown adipose tissue, the process could involve all UCPs. We
discuss the functional connection and physiological role of UCP and
alternative oxidase, two main energy-dissipating systems in the
plant-type mitochondrial respiratory chain of unicellular eukaryotes,
including the control of cellular energy balance as well as preventive
action against the production of reactive oxygen species.
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We provide evidence that ablation of uncoupling protein 1 increases
the rate of reactive oxygen containing species production (as detected
by Amplex Red) by mitochondria from brown adipose tissue, nomatter
what electron transport chain substrate is used (succinate plus rotenone
(about 1.5-fold, p=0.033), glycerol-3-phosphate (2-fold, p=0.030),
pyruvate plus malate (2-fold, p=0.044). The substrate glycerol-3-
phosphate resulted in the greatest amountof reactive oxygen containing
species production. Consistentwith these data are our observations that
(a) the mitochondrial membrane potential is maximal when is
uncoupling protein 1 is ablated and (b) oxygen consumption rates in
mitochondria from uncoupling protein 1 knock-out mice, are signifi-
cantly lower than those fromwild-typemice. In summary,we show that
uncoupling protein 1 can affect reactive oxygen containing species
production by isolated mitochondria from brown adipose tissue.
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The thymus is a primary lymphoid organ the progenitor cells of
which develop into mature thymocytes. Following antigen selection
processes these CD4/CD8 double positive cells develop into naïve single
positive (CD4 or CD8) T cells which migrate to the peripheral lymphoid
tissue, such as spleen and lymph nodes. This maturation and selection
process results in the apoptosis of 90% of thymocytes. UCP1 has been
shown tobepresent inmouse thymocyte butnot spleenocytemitochon-
dria. Flowcytometric analysis of cell profiles in thymusand spleens show
that there are (i) more immature double positive thymocytes in thymus
[10% increase, p=0.04] and spleen [2-fold increase, p=0.02] and (ii) less
single positive CD8 (mature) thymocytes in the thymus [2-fold decrease,
p=0.002] and spleen [2-fold decrease, p=0.01] of UCP1−/− mice
compared to wild-type C57Bl/6 mice [x-fold, p value]. In an endeavour
to explain these cell profile differences, we were able to show that spon-
taneous apoptosis is less prevalent in thymocytes isolated from UCP1−/−
mice compared to those isolated from C57Bl/6 mice [20% decrease,
p=0.006], indicating a role for UCP1 in T-cell selection in the thymus.
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